Dr. Pierre Redelinghuys
Advisory Board
Back to About

Dr. Pierre Redelinghuys

HMD Senior Scientist & Strategic Board Advisor

Dr. Pierre Redelinghuys is a scientist, educator, strategic advisor, and life sciences leader with over 20 years of experience spanning biomedical research, medical education, pharmaceuticals, innovation, project and portfolio leadership, organizational transformation, and strategic decision-making.

He holds a Ph.D. in Medical Biochemistry from the University of Cape Town and completed postdoctoral training in Immunology at the Universities of Dundee and Aberdeen in Scotland. His academic career included research and education, with extensive experience supporting medical education program delivery. He is an Associate Fellow of the Higher Education Academy (AdvanceHE) and a certified Project Management Professional (PMP).

In the pharmaceutical and life sciences sector, Pierre has held senior project and portfolio leadership positions at AstraZeneca, Kymab, and Abzena, leading complex global programs and multidisciplinary teams through critical development and investment decisions. His experience includes strategic governance, portfolio management, stakeholder alignment, investment proposal development, organizational transformation, and implementing enterprise project-management systems.

At HMD, Pierre brings scientific rigor and an enterprise-level strategic perspective to the development of the platform and its educational, scientific, and professional initiatives. As Senior Scientist, he contributes to the scientific integrity, academic quality, and strategic development of HMD’s medical and scientific content. As Strategic Board Advisor, he provides senior-level guidance on innovation, governance, organizational development, strategic decision-making, and the development of high-performing teams and programs.

Pierre is particularly passionate about helping organizations and professionals translate scientific knowledge into meaningful impact. His combination of scientific expertise, pharmaceutical industry leadership, academic experience, and coaching and mentoring capability supports HMD’s mission to equip physicians and healthcare professionals with the knowledge, leadership capabilities, and strategic perspective needed to shape the future of healthcare.

Other Team Members

Bakary Jatta, M.D.
Chair & Founder, HMD
Vanessa Nunes De Paiva, MBA, Ph.D.
Chief Physician Liaison, HMD
Tracy Lewis, M.A.Ed., B.S. Psych.
Chief Experience & Engagement Officer
Wes Scruggs, MBA
Commercial & Growth Officer, HMD
Minna Cross
HMD Data & Analytics Lead
Mandefro Ayano, M.D.
HMD Internal Medicine
Karthik Saravanan, BMBCh Bound, BA (Oxon)
Strategic Advisor For Medical AI & UK Programs, HMD
Tsion Yehualashet Wubshet, M.D.
HMD Regional Executive, East Africa
Chidinma Nwoha, MD, MPH
HMD Regional Executive, West Africa
Mohamed Benlamin, M.D.
HMD Internal Medicine
Fahmida Zahin, MBBS Candidate
HMD Ambassador, United Kingdom
Melody Olajide, MBBS Candidate
HMD Ambassador, West Africa
Praise Emmanuel, MD Candidate
HMD Ambassador, Southern Europe
Riya Dhindsa, MD Candidate
HMD Podcast Fellow
Howard Maibach, M.D., FAAD
Advisory Board Member, HMD
Alexander D. Crosett III
Board Director, HMD
Nancy DiGioacchino, MBA, CPHQ, CPCO, HACP, CIPM
Healthcare Governance, Risk & Compliance Board Advisor, HMD
Kendra Mitchell, JD
Independent Director & Strategic Counsel, HMD
Angelika Korelc
Operations & Transformation Board Advisor, HMD
Mina Ghorbanifarajzadeh, DMD
Board Advisor for Clinical AI Implementation & Validation, HMD
Parul Nanda
Technical Board Advisor & Technology Lead
Joe Sedlak, MBA, RN, BSN
Healthcare Technology, Commercial Growth & Enterprise Strategy Board Advisor
Lucia Domville, MIA, IRC®
Capital Markets, Investor Relations & Strategic Communications Board Advisor, HMD
Shelley Wisnowski, MHA, PT
Partnerships & Commercial Growth Board Advisor, HMD
Dan Gonzalez, PharmD
Clinical AI, Pharmacy & Digital Health Strategy Board Advisor, HMD
Melania Calinescu, PhD
AI & Data Strategy Board Advisor, HMD
Bryn Dunn
Finance, Capital & Corporate Strategy Advisor, HMD
Rachel Salazar, DHSc
Life Sciences, Clinical Innovation & Strategy Board Advisor, HMD